Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Ahuja Aparna, Directrice Médicale. Insider active across 1 company, notably T2 Biosystems, Inc.. Aggregated, 2 filings have been logged. Breakdown: 0 buy · 1 sell. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Aparna Ahuja is the Chief Medical Officer at T2 Biosystems, Inc. She oversees the company's medical initiatives, ensuring that products and services meet quality standards and regulatory requirements. Her role is essential in ensuring the scientific integrity of the company's operations.